MW4-14070-90083
5 vaccinations
2 coded responses
13 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
- 2021-01-07
- 2021-01-09
- 2021-01-10
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-21
-
2021-01-28
Dose 2 — Pfizer-BioNTech
-
2021-04-08
Survey response — 3 months, dose 1MedDRA: Uterine leiomyoma — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Uterine fibroid, likely unrelatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Report sent to call center — 3 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-08
-
2021-11-23
Dose 3 — Moderna
-
2022-01-09
Survey response — 12 months, dose 1MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy! · Healthcare visit (other): Healthy prenatal examMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2022-01-13
-
2022-01-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-13
Dose 4 — Moderna
-
2022-09-07
Dose 5 — Moderna
- 2022-10-09
- 2022-10-21
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech | No |
| 3 | 2021-11-23 | Moderna | No |
| 4 | 2022-04-13 | Moderna | No |
| 5 | 2022-09-07 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — 3 months, dose 1
Symptoms: Uterine fibroid, likely unrelated
Release 10 — 12 months, dose 1
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Uterine leiomyoma | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release